AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ २९.८९
arrow_downward
-०.८६%(-०.२६) 1D
US$ २९.८९
०.००% (०.००)
bedtimeAfter hours
Closed: नोभेम्बर १७, १६:००:०१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ ३०.०९
High
US$ ३०.३८
Low
US$ २८.९४
Mkt. cap
१.७९ अरब
Avg. vol.
१२.३३ लाख
Volume
६.६५ लाख
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ ३०.०९
High
US$ ३०.३८
Low
US$ २८.९४
Mkt. cap
१.७९ अरब
Avg. vol.
१२.३३ लाख
Volume
६.६५ लाख
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
BigGo Finance
·
१ घण्टा पहिले
New York Stocks Slip a Day Before Nvidia Earnings; S&P 500, Nasdaq Fall for Fourth Straight Session
ChartMill
·
२ घण्टा पहिले
S&P 500 After-Hours Gainers for Nov. 17, 2026
FXStreet
·
३ घण्टा पहिले
Dow Jones Industrial Average slides on NSA outage, then Nvidia beats
Traders Union
·
३ घण्टा पहिले
Ryan Detrick: Technology stocks outperformed S&P 500 while 75 stocks declined
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc